SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-327257
Filing Date
2018-11-15
Accepted
2018-11-15 07:32:08
Documents
56
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d617942d10q.htm 10-Q 704433
2 EX-10.6 d617942dex106.htm EX-10.6 112682
3 EX-10.7 d617942dex107.htm EX-10.7 288706
4 EX-31.1 d617942dex311.htm EX-31.1 7626
5 EX-31.2 d617942dex312.htm EX-31.2 7681
6 EX-32.1 d617942dex321.htm EX-32.1 5149
  Complete submission text file 0001193125-18-327257.txt   4412099

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT zsan-20180930.xml EX-101.INS 727826
8 XBRL TAXONOMY EXTENSION SCHEMA zsan-20180930.xsd EX-101.SCH 44344
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zsan-20180930_cal.xml EX-101.CAL 52434
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zsan-20180930_def.xml EX-101.DEF 156647
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20180930_lab.xml EX-101.LAB 392769
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20180930_pre.xml EX-101.PRE 274412
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36570 | Film No.: 181185968
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences